USANA Health Sciences (USNA) Misses Q2 EPS by 17c; Lowers Outlook, $100M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
USANA Health Sciences Reports Second Quarter Financial Results
July 25, 2017 4:17 PM EDTSecond quarter net sales were $257.1 million, a decrease of 0.6% year-over-year, but up 2.3% in constant currency Number of active Customers1 at quarter end increased 1.8% to 567,000 Second quarter EPS of $0.93, or $0.98 excluding incremental expense related to the Companys internal investigation of its China operations disclosed in February 2017 Company revises 2017 Outlook Share repurchase authorization increased to $100 million
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial... More
